|
Active substance |
caplacizumab |
|
Holder |
Sanofi |
|
Status |
Closed |
|
Indication |
acquired thrombotic thrombocytopenic purpura |
|
Public documents |
|
|
Last update |
03/09/2019 |
Cablivi
Last updated on 10/09/2024